Results 41 to 50 of about 21,501 (259)

Hypersensitivity reaction risk when restarting cenobamate after discontinuation: Insights from a prolonged hospitalized cohort

open access: yesEpilepsia Open, EarlyView.
Abstract Objective To evaluate the risk of hypersensitivity reactions, including dermatological rashes, when cenobamate (CNB) is restarted at maintenance doses after temporary discontinuation. Methods We leveraged the natural experiment of long antiseizure medication discontinuation during intracranial EEG evaluation and conducted a retrospective ...
Marina Feldman   +4 more
wiley   +1 more source

Advances in the Diagnosis of Drug Eruptions

open access: yesActas Dermo-Sifiliográficas (English Edition), 2013
Drug eruptions affecting the skin or mucosas (toxicoderma) are the most common adverse effects of drugs and represent one of the more common diagnostic challenges for the dermatologist. A better understanding of the pathogenic mechanisms of drug reactions, pharmacogenetics, and pharmacoepidemiology will help us to resolve the main dilemmas and to ...
De La Torre Fraga, José Carlos   +1 more
openaire   +3 more sources

Cheek tooth extraction in geriatric versus non‐geriatric horses

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Age‐related dental changes are major contributors to dental disorders in older horses, and cheek tooth extractions are often required to maintain masticatory function and oral comfort. However, limited information is available on clinical and treatment characteristics in this older patient population.
Elias Mair   +4 more
wiley   +1 more source

Inflammation Unchecked: Concurrent KD and SJS in an 18‐Month‐Old Child

open access: yes
Arthritis Care &Research, Accepted Article.
Catherine Deffendall   +6 more
wiley   +1 more source

Impact of cystic fibrosis transmembrane conductance regulator modulator therapies on liver stiffness and liver enzymes: An observational perspective single‐center cohort study

open access: yesJPGN Reports, EarlyView.
Abstract Objectives The efficacy of cystic fibrosis transmembrane conductance regulator (CFTR)‐modulator therapies in preventing or ameliorating cystic fibrosis liver disease (CFLD) by correcting CFTR in cholangiocytes is not well‐documented. This study aimed to assess liver function during CFTR‐modulators.
Laura Giugliano   +12 more
wiley   +1 more source

A Rare Case Report of Localized Bullous Fixed Drug Eruption Due to Tamsulosin

open access: yesJK Science, 2023
Fixed drug eruption is a cutaneous adverse reaction to a specific drug. Tamsulosin is an alpha-1 adrenergic receptor blocker used to treat benign prostatic hyperplasia in men.
Sheba Mariam Jacob   +3 more
doaj  

Health‐Related Quality of Life in Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Qualitative Study

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 577-580, June 2026.
ABSTRACT Background Epidermal necrolysis (EN), including Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are severe cutaneous drug reactions with high morbidity. However, the quality of life (QoL) impact during acute hospitalization is not well understood.
Jacob McFeeters   +9 more
wiley   +1 more source

Hypopigmented penile fixed drug eruption

open access: yesClinical Case Reports, 2022
Fixed drug eruptions (FDE) are typically associated with residual hyperpigmentation or non‐pigmenting lesions. There is no distinctive histopathological feature; though, drug provocation tests (DPT) can be confirmatory within 7 days.
Perpetua U. Ibekwe   +5 more
doaj   +1 more source

A Case of Pembrolizumab‐Induced Pityriasis Lichenoides‐Like Eruption Treated Successfully With Dupilumab

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 644-647, June 2026.
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou   +2 more
wiley   +1 more source

Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit

open access: yesCase Reports in Dermatology, 2017
A lichenoid drug eruption is a rare side effect which can occur following the administration of several different medications. Here we describe a unique case of fenofibrate as the causative agent of a lichenoid drug eruption.
Fayeza Mohammed   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy